(Q44074154)

29 November 2017

Risk factors for nephrolithiasis in patients with familial idiopathic hypercalciuria (English)

1 reference

29 November 2017

Nicolas Lerolle

1

1 reference

29 November 2017

Brigitte Lantz

2

1 reference

29 November 2017

Françoise Paillard

3

1 reference

29 November 2017

Bernard Gattegno

4

1 reference

29 November 2017

Antoine Flahault

5

1 reference

29 November 2017

Pierre Ronco

6

1 reference

29 November 2017

Pascal Houillier

7

1 reference

29 November 2017

Eric Rondeau

8

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

American Journal of Medicine

29 November 2017

1 reference

29 November 2017

113

1 reference

29 November 2017

2

1 reference

29 November 2017

99-103

1 reference

Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol.

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901152-X

The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stone of renal origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901152-X

Familial idiopathic hypercalciuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901152-X

Idiopathic hypercalciuria and hyperuricosuria: family prevalence of nephrolithiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901152-X

Family investigations in idiopathic hypercalciuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901152-X

Autosomal dominant inheritance of hypercalciuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901152-X

Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901152-X

Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901152-X

Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901152-X

Renal mass and reserve of vitamin D: determinants in primary hyperparathyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901152-X

Pathophysiological Studies in Idiopathic Hypercalciuria: Use of an Oral Calcium Tolerance Test to Characterize Distinctive Hypercalciuric Subgroups*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901152-X

Oral calcium tolerance test in the early diagnosis of primary hyperparathyroidism and multiple endocrine neoplasia type 1 in patients with the Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901152-X

The assessment of phosphate reabsorption.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901152-X

Familial Absorptive Hypercalciuria in a Large Kindred

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901152-X

Family History of Renal Stones in a Population Study of Stone-formers and Healthy Subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901152-X

Mechanism for calcium urolithiasis among patients with hyperuricosuria: supersaturation of urine with respect to monosodium urate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901152-X

The contribution of dietary purine over-consumption to hyperpuricosuria in calcium oxalate stone formers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901152-X

Randomized trial of allopurinol in the prevention of calcium oxalate calculi.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901152-X

Importance of dietary sodium in the hypercalciuria syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901152-X

Interrelationships between urinary sodium, calcium, hydroxyproline and serum PTH in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901152-X

10.1016/S0002-9343(02)01152-X

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference